The STOP COVID 2 study: Fluvoxamine vs placebo for outpatients with symptomatic COVID-19, a fully remote randomized controlled trial

Authors

Angela M Reiersen, Washington University School of Medicine in St. Louis
Caline Mattar, Washington University School of Medicine in St. Louis
J Philip Miller, Washington University School of Medicine in St. Louis
William G Powderly, Washington University School of Medicine in St. Louis
Michael W Rich, Washington University School of Medicine in St. Louis
Julie Schweiger, Washington University School of Medicine in St. Louis
Angela Stevens, Washington University School of Medicine in St. Louis
Lei Yang, Washington University School of Medicine in St. Louis
Michael Yingling, Washington University School of Medicine in St. Louis
Torie R Gettinger, Washington University School of Medicine in St. Louis
Charles F Zorumski, Washington University School of Medicine in St. Louis
Eric J Lenze, Washington University School of Medicine in St. Louis
et al.

Journal

Open Forum Infectious Diseases

Publication Date

8-1-2023

Volume

10

Issue

8

First Page

ofad419

Document Type

Open Access Publication

DOI

10.1093/ofid/ofad419

Rights and Permissions

Angela M Reiersen, Caline Mattar, Rachel A Bender Ignacio, David R Boulware, Todd C Lee, Rachel Hess, Alexander J Lankowski, Emily G McDonald, J Philip Miller, William G Powderly, Matthew F Pullen, Jeffrey T Rado, Michael W Rich, Joshua T Schiffer, Julie Schweiger, Adam M Spivak, Angela Stevens, Simone N Vigod, Payal Agarwal, Lei Yang, Michael Yingling, Torie R Gettinger, Charles F Zorumski, Eric J Lenze, The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial, Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad419, https://doi.org/10.1093/ofid/ofad419. https://academic.oup.com/ofid/article/10/8/ofad419/7238414?login=true. © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Reiersen, Angela M; Mattar, Caline; Miller, J Philip; Powderly, William G; Rich, Michael W; Schweiger, Julie; Stevens, Angela; Yang, Lei; Yingling, Michael; Gettinger, Torie R; Zorumski, Charles F; Lenze, Eric J; and et al., "The STOP COVID 2 study: Fluvoxamine vs placebo for outpatients with symptomatic COVID-19, a fully remote randomized controlled trial." Open Forum Infectious Diseases. 10, 8. ofad419 (2023).
https://digitalcommons.wustl.edu/oa_4/2253

Department

ICTS (Institute of Clinical and Translational Sciences), Psychiatry

Additional Links

Supplemental material is available for this article at publisher site.